A Randomized, Double-blind, Active-controlled Phase III Trial of a Cell Culture-derived Quadrivalent Inactivated Influenza Vaccine in Healthy South Korean Children and Adolescents 6 Months to 18 Years of Age
2019 ◽
Vol 38
(9)
◽
pp. e209-e215
◽
Keyword(s):